SCI时时刷

search
+
Carcinocythemia diagnosed on peripheral blood clot sections
Carcinocythemia diagnosed on peripheral blood clot sections
Authors and AffiliationsDepartment of Haematological Medicine, King’s College Hospital NHS Foundation Trust, Denmark Hill,...
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis
The Japanese Society on Thrombosis and Hemostasis (JSTH) published the first-ever disseminated intravascular coagulation (...
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02
A practice-oriented genome-profiling study for acute myeloid leukemia using the novel HANDLE system: HM-screen-JAPAN02
HM-SCREEN-Japan is a multicenter collaborative project in Japan to evaluate the clinical utility of a cancer genome panel ...
Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factors
Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factors
This study investigated the efficacy of tisagenlecleucel (tisa-cel) and allogeneic hematopoietic stem cell transplantation...
Chimerism analysis by ABO blood group genotyping with digital droplet PCR
Chimerism analysis by ABO blood group genotyping with digital droplet PCR
Chimerism analysis is an important post-transplant assessment for allogeneic hematopoietic stem cell transplant (HCT) reci...
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 2: hematologic malignancy
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 2: hematologic malignancy
Disseminated intravascular coagulation (DIC) associated with hematologic malignancies, particularly acute promyelocytic le...
Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan
Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan
Recent trends in the treatment of primary immune thrombocytopenia (ITP) were investigated using a claims database that inc...
Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia
Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia
Inotuzumab ozogamicin (InO), a CD22-directed antibody conjugated to calicheamicin, has demonstrated excellent efficacy in ...
Temporal changes in corticosteroid dose during ibrutinib treatment in patients with cGVHD and pulmonary involvement
Temporal changes in corticosteroid dose during ibrutinib treatment in patients with cGVHD and pulmonary involvement
The GVH3001 study assessed the efficacy and safety of ibrutinib in Japanese patients with steroid-dependent or -refractory...
Graft CD8+ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies
Graft CD8+ T cells for improving event-free survival after T cell-replete haploidentical stem cell transplantation in children with hematological malignancies
T cell-replete haploidentical hematopoietic stem cell transplantation (TCR-haplo-HSCT) is a potentially curative therapy f...
Clonal hematopoiesis in cancer predisposition syndromes
Clonal hematopoiesis in cancer predisposition syndromes
After recent advances in sequencing technologies led to the discovery of novel genes associated with predisposition to hem...
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature
We herein report a rare case of acute myeloid leukemia (AML) with t(11;12)(p15;q13) and NUP98::RARG, which seems to be inv...
A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples
A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples
Prolonged activated partial thromboplastin time (aPTT) in plasma samples requires quick and accurate differential diagnosi...
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB
Peripheral T cell lymphoma (PTCL) is an aggressive and highly heterogeneous lymphoma with a bleak prognosis, highlighting ...
Comparison of busulfan pharmacokinetics between four-times-daily and once-daily administration in pediatric patients: a preliminary prospective observational trial
Comparison of busulfan pharmacokinetics between four-times-daily and once-daily administration in pediatric patients: a preliminary prospective observational trial
Therapeutic drug monitoring (TDM) of busulfan (BU) is useful for achieving the target area under the curve (AUC) because i...
Dexamethasone palmitate for children with Epstein-Barr virus associated hemophagocytic lymphohistiocytosis
Dexamethasone palmitate for children with Epstein-Barr virus associated hemophagocytic lymphohistiocytosis
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) has a wide range of clinical presentations and ...
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM
We characterized the safety and efficacy of the bispecific antibody teclistamab in Japanese patients with relapsed/refract...
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphoma
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphoma
Here, we investigated the clinical significance of NOTCH1 and FBXW7 alterations for adult T-cell leukemia/lymphoma (ATLL) ...
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
Ibrutinib is a first-in-class Bruton’s tyrosine kinase inhibitor that is approved for the treatment of chronic lymph...
A case of autoimmune factor XIII deficiency due to clearance-accelerating and inhibitory anti-FXIII autoantibodies
A case of autoimmune factor XIII deficiency due to clearance-accelerating and inhibitory anti-FXIII autoantibodies
A 63-year-old man, previously diagnosed with multiple autoimmune diseases, developed life-threatening bleeding after gastr...
JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN)
JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN)
Conflict of interest KS has received per diem, including speaking f...
Impact of stem cell source on secondary steroid for chronic GVHD after allogeneic hematopoietic cell transplantation
Impact of stem cell source on secondary steroid for chronic GVHD after allogeneic hematopoietic cell transplantation
Inappropriate discontinuation of immunosuppressive drugs (ISD) following allogeneic hematopoietic cell transplantation (HC...
Real-world toxicity and efficacy of asciminib in heavily pretreated patients with chronic myeloid leukemia
Real-world toxicity and efficacy of asciminib in heavily pretreated patients with chronic myeloid leukemia
Although tyrosine kinase inhibitors (TKIs) have improved the prognosis of chronic myeloid leukemia (CML), some patients do...
Safety and effectiveness of lenalidomide in Japanese patients with relapsed/refractory ATLL: post-marketing surveillance
Safety and effectiveness of lenalidomide in Japanese patients with relapsed/refractory ATLL: post-marketing surveillance
Lenalidomide is an oral immunomodulatory agent approved for the treatment of relapsed/refractory adult T-cell leukemia/lym...
Current treatment approach and future perspectives in B cell lymphoma
Current treatment approach and future perspectives in B cell lymphoma
Diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) represent the two major subtypes of mature B cell lymph...
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes
Luspatercept has shown durable clinical efficacy for the treatment of anemia in transfusion-dependent patients with lower-...
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease
Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease
Ganciclovir and foscarnet are two representative anti-cytomegalovirus (CMV) agents. A previous regional study revealed a l...
Successful complete remission after induction therapy with CPX-351 for acute myeloid leukemia with myelodysplasia-related changes accompanied by double-minute chromosomes and MYC gene amplification
Successful complete remission after induction therapy with CPX-351 for acute myeloid leukemia with myelodysplasia-related changes accompanied by double-minute chromosomes and MYC gene amplification
Cite this articleSaburi, M., Nishikawa, T., Kawano, K. et al. Successful complete remission after induction therapy with C...
Iron deficiency and phlebotomy in patients with polycythemia vera
Iron deficiency and phlebotomy in patients with polycythemia vera
Polycythemia vera (PV) is a myeloproliferative neoplasm that is associated with an elevated risk of thrombosis. Treatment ...
CD34+ and CD34− MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells
CD34+ and CD34− MM cells show different immune-checkpoint molecule expression profiles: high expression of CD112 and CD137 ligand on CD34+ MM cells
Despite the introduction of new drugs, multiple myeloma (MM) still remains incurable. We previously reported that CD34+ MM...
阅读更多
format_indent_increase